Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22972

1.

Blockade of IL-6 signaling prevents paclitaxel-induced neuropathy in C57Bl/6 mice.

Huehnchen P, Muenzfeld H, Boehmerle W, Endres M.

Cell Death Dis. 2020 Jan 22;11(1):45. doi: 10.1038/s41419-020-2239-0.

PMID:
31969555
2.

Newly onset indirect traumatic optic neuropathy-surgical treatment first versus steroid treatment first.

Yu B, Ma YJ, Tu YH, Wu WC.

Int J Ophthalmol. 2020 Jan 18;13(1):124-128. doi: 10.18240/ijo.2020.01.18. eCollection 2020.

3.

Risk of adverse events in lymphoma patients treated with brentuximab vedotin: a systematic review and meta-analysis.

Gao S, Zhang M, Wu K, Zhu J, He Z, Li J, Chen C, Qiu K, Yu X, Wu J.

Expert Opin Drug Saf. 2020 Jan 20. doi: 10.1080/14740338.2020.1718103. [Epub ahead of print]

PMID:
31955620
4.

A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer.

Sardesai S, Badawi M, Mrozek E, Morgan E, Phelps M, Stephens J, Wei L, Kassem M, Ling Y, Lustberg M, Stover D, Williams N, Layman R, Reinbolt R, VanDeusen J, Cherian M, Grever M, Carson W, Ramaswamy B, Wesolowski R.

Invest New Drugs. 2020 Jan 17. doi: 10.1007/s10637-020-00895-5. [Epub ahead of print]

PMID:
31953695
5.

A new approach to characterize postural deficits in chemotherapy-induced peripheral neuropathy and to analyze postural adaptions after an exercise intervention.

Kneis S, Wehrle A, Dalin D, Wiesmeier IK, Lambeck J, Gollhofer A, Bertz H, Maurer C.

BMC Neurol. 2020 Jan 16;20(1):23. doi: 10.1186/s12883-019-1589-7.

6.

Brentuximab vedotin with chemotherapy for Stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study.

Straus DJ, Długosz-Danecka M, Alekseev S, Illes A, Picardi M, Lech-Maranda E, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Ramchandren R, Zinzani PL, Hutchings M, Connors JM, Radford J, Munoz J, Kim WS, Advani R, Ansell SM, Younes A, Miao H, Liu R, Fenton K, Forero A, Gallamini A.

Blood. 2020 Jan 16. pii: blood.2019003127. doi: 10.1182/blood.2019003127. [Epub ahead of print]

PMID:
31945149
7.

High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN).

Mekhail NA, Argoff CE, Taylor RS, Nasr C, Caraway DL, Gliner BE, Subbaroyan J, Brooks ES.

Trials. 2020 Jan 15;21(1):87. doi: 10.1186/s13063-019-4007-y.

8.

Linezolid for the treatment of extensively drug-resistant tuberculosis: a systematic review and meta-analysis.

Lifan Z, Sainan B, Feng S, Siyan Z, Xiaoqing L.

Int J Tuberc Lung Dis. 2019 Dec 1;23(12):1293-1307. doi: 10.5588/ijtld.18.0822.

PMID:
31931914
9.

Study protocol for a randomized controlled trial on the effect of the Diabetic Foot Guidance System (SOPeD) for the prevention and treatment of foot musculoskeletal dysfunctions in people with diabetic neuropathy: the FOotCAre (FOCA) trial I.

Ferreira JSSP, Cruvinel Junior RH, Silva EQ, Veríssimo JL, Monteiro RL, Pereira DS, Suda EY, Sartor CD, Sacco ICN.

Trials. 2020 Jan 13;21(1):73. doi: 10.1186/s13063-019-4017-9.

10.

Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.

Salehifar E, Janbabaei G, Hendouei N, Alipour A, Tabrizi N, Avan R.

Clin Drug Investig. 2020 Jan 10. doi: 10.1007/s40261-019-00882-6. [Epub ahead of print]

PMID:
31925721
11.
12.

Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis.

Sun J, Wang Y, Zhang X, Zhu S, He H.

Prim Care Diabetes. 2020 Jan 6. pii: S1751-9918(19)30284-0. doi: 10.1016/j.pcd.2019.12.005. [Epub ahead of print]

PMID:
31917119
13.

The effectiveness and safety of acupuncture therapy for Guillain-Barré syndrome: A systematic review and meta-analysis protocol.

Fan Z, Liu B, Zhang Y, Li M, Lu T.

Medicine (Baltimore). 2020 Jan;99(2):e18619. doi: 10.1097/MD.0000000000018619.

14.

Prevalence and management of diabetic neuropathy in secondary care in Qatar.

Ponirakis G, Elhadd T, Chinnaiyan S, Dabbous Z, Siddiqui M, Al-Muhannadi H, Petropoulos I, Khan A, Ashawesh KAE, Dukhan KMO, Mahfoud ZR, Murgatroyd C, Slevin M, Malik RA.

Diabetes Metab Res Rev. 2020 Jan 8:e3286. doi: 10.1002/dmrr.3286. [Epub ahead of print]

PMID:
31913560
15.

Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy.

Beijers AJM, Bonhof CS, Mols F, Ophorst J, de Vos-Geelen J, Jacobs EMG, van de Poll-Franse LV, Vreugdenhil G.

Ann Oncol. 2020 Jan;31(1):131-136. doi: 10.1016/j.annonc.2019.09.006.

PMID:
31912787
16.

Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study.

Park SJ, Kim J, Kim HS, Lee JW, Chang HK, Lee KH, Kim DY, Kim S, Chang SJ, Han SS, Park SY, Shim SH.

J Gynecol Oncol. 2019 Sep 10. doi: 10.3802/jgo.2020.31.e15. [Epub ahead of print]

17.

Application of Topical Oxygen Therapy in Healing Dynamics of Diabetic Foot Ulcers - A Systematic Review.

Nataraj M, Maiya AG, Karkada G, Hande M, Rodrigues GS, Shenoy R, Prasad SS.

Rev Diabet Stud. 2019;15:74-82. doi: 10.1900/RDS.2019.15.74. Epub 2019 Dec 30.

PMID:
31904759
18.

Expressions of spinal microglia activation, BDNF, and DREAM proteins correlated with formalin-induced nociceptive responses in painful and painless diabetic neuropathy rats.

Ismail CAN, Suppian R, Ab Aziz CB, Long I.

Neuropeptides. 2020 Feb;79:102003. doi: 10.1016/j.npep.2019.102003. Epub 2019 Dec 24.

PMID:
31902597
19.

Cycle Training improves vascular function and neuropathic symptoms in patients with type 2 diabetes and peripheral neuropathy: A randomized controlled trial.

Gholami F, Nazari H, Alimi M.

Exp Gerontol. 2019 Dec 31;131:110799. doi: 10.1016/j.exger.2019.110799. [Epub ahead of print]

PMID:
31899340
20.

[Indication of tracheostomy extubation in patients with severe neuropathy: a Meta-analysis].

Ding Y, Xu S, Zhang W, Zhang B.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Nov;31(11):1378-1383. doi: 10.3760/cma.j.issn.2095-4352.2019.11.013. Chinese.

Supplemental Content

Loading ...
Support Center